Our website is currently undergoing a makeover and will be up and running in no time .
The Technion Society of Australia aims to establish a lasting relationship between Australian society and the Technion – Israel Institute of Technology.
MAke an impact
Cancer is Australia’s leading cause of burden of disease. Pancreatic Cancer is considered among the deadliest and most aggressive and is associated with an extremely high mortality rate.
Technion’s researchers, led by A. Prof. Ester Segal, are developing a lab-on-a-chip technology to allow sensitive and rapid detection of pancreatic cancer biomarkers at the initiation stages (precursor stages to malignant cancer and the ideal stage for diagnosis).
Producing results within minutes these cost-effective biosensing devices could be employed for a population-wide screening test for pancreatic cancer in the clinic or at home.